AWM
IDXX icon

Atticus Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Atticus Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$537 – 393
2025
Q2 		$537 Buy
+1
New +$478 ﹤0.01% 633
2022
Q4 		– Sell
-5
Closed -$2K – 585
2022
Q3 		$2K Hold
5
– – ﹤0.01% 501
2022
Q2 		$2K Hold
5
– – ﹤0.01% 534
2022
Q1 		$3K Buy
+5
New +$2.63K ﹤0.01% 497

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Atticus Wealth Management's IDXX Position: Q3 2025 in Review

Atticus Wealth Management sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 1 share — an estimated $537 sold.

Atticus Wealth Management first reported a position in IDXX in Q1 2022 and held it in 4 quarters. The position peaked at $3K in Q1 2022. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Atticus Wealth Management reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 1 Idexx Laboratories share in Q3 2025, an estimated $537.
  • Atticus Wealth Management first reported a position in Idexx Laboratories in Q1 2022 and held it in 4 quarters.
  • Atticus Wealth Management's Idexx Laboratories position peaked at $3K in Q1 2022.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.